Related Experiment Video

Updated: Oct 29, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Individualized mobile health interventions for cardiovascular event prevention in patients with coronary heart

Yuling Chen1,2,3, Meihua Ji1,4, Ying Wu5

  • 1School of Nursing, Capital Medical University, 10 You-an-men Wai Xi-tou-tiao, Feng-Tai District, Beijing, 100069, China.

BMC Cardiovascular Disorders
|July 14, 2021
PubMed

Insights

Mobile health interventions using the iCARE system may reduce cardiovascular events in coronary heart disease patients. This study investigates the effectiveness of individualized mHealth interventions for cardiovascular risk management.

Area of Science:

  • Cardiology
  • Digital Health
  • Preventive Medicine

Background:

  • Mobile health (mHealth) interventions show promise for managing cardiovascular risk factors.
  • Individualized interventions are key for effective cardiovascular disease management.

Purpose of the Study:

  • To assess the efficacy of the Individualized Cardiovascular Application system for Risk Elimination (iCARE) in reducing major cardiovascular events.
  • To evaluate the impact of mHealth-based individualized interventions on secondary prevention in coronary heart disease (CHD) patients.

Main Methods:

  • A large-scale, multi-center, randomized controlled trial involving 2820 CHD patients.
  • Participants were randomized into three groups: iCARE with rich media, iCARE with text only, and standard care.
  • Follow-up occurred at 1, 3, 6, 12, 24, and 36 months, with the primary outcome being major cardiovascular events within 3 years.

Main Results:

  • Primary outcome: incidence of major cardiovascular events within 3 years.
  • Secondary outcomes: changes in health behaviors, medication adherence, and cardiovascular health score.

Conclusions:

  • The iCARE trial will provide empirical evidence for mHealth-based secondary preventive care in CHD patients.
  • Results will guide future research in intelligent, individualized cardiovascular risk management.
Abstract

Keywords:
Cardiovascular eventsCoronary heart diseaseHealth behaviorMedication adherenceMobile healthNursing

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function05:03

Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function

Published on: December 11, 2019

8.8K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
77
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
75
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
82
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
164